Journal article · 2026
Pelacarsen and Cardiovascular Outcomes in Patients with High Lipoprotein(a)
New England Journal of Medicine · Published 7 November 2026 · DOI 10.1056/nejmoa2610159
In brief
“Pelacarsen and Cardiovascular Outcomes in Patients with High Lipoprotein(a)” is a 2026 journal article by Leslie Cho and 20 co-authors, published in New England Journal of Medicine. OpenAlex counts 1 citations as of 16 November 2026, which puts it in the top 6% of works published in 2026 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 1
- Most cited in
- 2026 (1)
- Field-weighted impact
- 6.08
- References
- 20
- Authors
- 21
Abstract
BACKGROUND: Pelacarsen, an antisense oligonucleotide, reduces serum levels of lipoprotein(a). However, the effect of pelacarsen on cardiovascular outcomes remains uncertain. METHODS: We conducted an international, randomized, placebo-controlled trial involving patients with preexisting cardiovascular disease and a lipoprotein(a) level of at least 70 mg per deciliter. Patients were randomly assigned in a 1:1 ratio to receive… Read the full abstract at the publisher.
Excerpt. This paper is not open access.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Cho, L., Nicholls, S. J., Frndak, S., Wolski, K., Nordestgaard, B. G., Manning, B., Leitersdorf, E., Landmesser, U., Menon, V., McCluskey, J., Blaha, M. J., Morishita, R., Lincoff, A. M., Zhao, Z., Wang, J., Santos, R. D., Gouni‐Berthold, I., Tsimikas, S., Lesogor, A., . . . Nissen, S. E. (2026). Pelacarsen and Cardiovascular Outcomes in Patients with High Lipoprotein(a). New England Journal of Medicine. https://doi.org/10.1056/nejmoa2610159
MLA 9
Cho, Leslie, et al. “Pelacarsen and Cardiovascular Outcomes in Patients with High Lipoprotein(a).” New England Journal of Medicine, 2026. https://doi.org/10.1056/nejmoa2610159.
Chicago
Cho, Leslie, Stephen J Nicholls, Seth Frndak, Kathy Wolski, Børge Grønne Nordestgaard, Brian Manning, Eran Leitersdorf, et al. 2026. “Pelacarsen and Cardiovascular Outcomes in Patients with High Lipoprotein(a).” New England Journal of Medicine. https://doi.org/10.1056/nejmoa2610159.
Harvard
Cho, L. et al. (2026) ‘Pelacarsen and Cardiovascular Outcomes in Patients with High Lipoprotein(a)’, New England Journal of Medicine. doi:10.1056/nejmoa2610159.
IEEE
L. Cho et al., “Pelacarsen and Cardiovascular Outcomes in Patients with High Lipoprotein(a),” New England Journal of Medicine, 2026, doi: 10.1056/nejmoa2610159.
BibTeX
@article{cho2026pelacarsen,
title = {{Pelacarsen and Cardiovascular Outcomes in Patients with High Lipoprotein(a)}},
author = {Cho, Leslie and Nicholls, Stephen J and Frndak, Seth and Wolski, Kathy and Nordestgaard, Børge Grønne and Manning, Brian and Leitersdorf, Eran and Landmesser, Ulf and Menon, Venu and McCluskey, Jackie and Blaha, Michael Joseph and Morishita, Ryuichi and Lincoff, Abraham Michael and Zhao, Ziqiang and Wang, Jing and Santos, Raul Dias and Gouni‐Berthold, Ioanna and Tsimikas, Sotirios and Lesogor, Anastasia and Cao, Hui and Nissen, Steven E.},
journal = {New England Journal of Medicine},
year = {2026},
doi = {10.1056/nejmoa2610159},
url = {https://doi.org/10.1056/nejmoa2610159}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- pelacarsen
- lipoprotein(a)
- antisense oligonucleotides
- major adverse cardiovascular events
- cardiovascular outcomes
- pre-existing cardiovascular disease
- hyperlipidemia
- lipid-lowering therapy
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Cho, L., Nicholls, S. J., Frndak, S., Wolski, K., Nordestgaard, B. G., Manning, B., Leitersdorf, E., Landmesser, U., Menon, V., McCluskey, J., Blaha, M. J., Morishita, R., Lincoff, A. M., Zhao, Z., Wang, J., Santos, R. D., Gouni‐Berthold, I., Tsimikas, S., Lesogor, A., . . . Nissen, S. E. (2026). Pelacarsen and Cardiovascular Outcomes in Patients with High Lipoprotein(a). New England Journal of Medicine. https://doi.org/10.1056/nejmoa2610159
How many times has this paper been cited?
1 times, according to OpenAlex on 16 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Leslie Cho, Stephen J Nicholls, Seth Frndak, Kathy Wolski, Børge Grønne Nordestgaard, Brian Manning, Eran Leitersdorf, Ulf Landmesser, Venu Menon, Jackie McCluskey, Michael Joseph Blaha, Ryuichi Morishita and 9 more.
What is the DOI of this paper?
10.1056/nejmoa2610159, permanently at https://doi.org/10.1056/nejmoa2610159. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 16 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.